Transgender Health Quiz Endocrine Society Guideline

According to the American Psychiatric Association's current classification system, what term is used to diagnose persons who are not satisfied with their designated gender?

What term did Magnus Hirschfeld coin in 1923 to describe people who want to live a life that corresponds with their experienced gender vs their designated gender?

Which organization published the first Standards of Care for treating persons with GD/gender incongruence in 1979?

What is one of the future needs for endocrine treatment protocols for GD/gender incongruence mentioned in the guideline?

What is the main factor that increases the likelihood of childhood GD/gender incongruence persisting into adolescence?

According to DSM-5 criteria for gender dysphoria, how long must a marked incongruence between one's experienced/expressed gender and natal gender persist?

What is one of the DSM-5 criteria for gender dysphoria related to primary and/or secondary sex characteristics?

According to ICD-10 criteria for Transsexualism, how long should the transsexual identity be present persistently?

During the diagnostic procedure for adolescents, what type of evaluation should be included to assess the family's ability?

What is the primary focus of counseling during social transitioning?

Which of the following is NOT a criterion for gender-affirming hormone therapy for adults?

When are adolescents eligible for GnRH agonist treatment?

What are the criteria for trained mental health professionals (MHPs) to diagnose GD/gender incongruence in adults?

What is the main reason for using puberty-suppressing medication in adolescents with gender dysphoria or gender incongruence?

At which Tanner stage is it recommended to start pubertal suppression for adolescents with gender dysphoria/gender incongruence?

Which medication is recommended for suppressing pubertal hormones in adolescents with gender dysphoria/gender incongruence?

What is the primary reason for starting puberty suppression early in adolescents with GD/gender incongruence?

What are some potential risks of pubertal suppression in GD/gender-incongruent adolescents?

What is the suggested frequency of monitoring anthropometry and Tanner stages during suppression of puberty?

Which diagnostic tool can be used to assess bone mineral density (BMD) in adolescents undergoing puberty suppression treatment?

What is the recommended age for most adolescents to have sufficient mental capacity to give informed consent for sex hormone treatment?

What is the suggested frequency for monitoring laboratory parameters such as LH, FSH, E2/T, and 25OH vitamin D during suppression of puberty?

For adolescents who request sex hormone treatment, which professionals should confirm the persistence of GD/gender incongruence and sufficient mental capacity to give informed consent?

During the induction of puberty, what is the suggested frequency for monitoring clinical pubertal development in adolescents?

At what age do many adolescents achieve a reasonable level of competence for medical decision-making?

Which professionals should be involved in monitoring an adolescent throughout pubertal induction?

Which method of administering testosterone is mentioned as an option for transgender male adolescents during pubertal induction?

What are the two major goals of hormonal therapy for transgender adults?

Which medical conditions should be evaluated and addressed before beginning hormone therapy?

What should clinicians measure during hormone treatment?

What should the treatment team for a transgender individual include?

What is the responsibility of the treating clinician in confirming the criteria for treatment?

What should the treating clinician discuss with the patient before starting hormone treatment?

Which hormone is commonly used to induce masculinization in transgender males?

What are some of the effects of testosterone treatment in transgender males?

What can be done if uterine bleeding continues despite testosterone treatment in transgender males?

What is the typical testosterone value range for transgender males?

Which route of administration is NOT mentioned for testosterone therapy in transgender males?

What method can be used to stop menses prior to testosterone treatment in transgender males?

Why is treatment with physiologic doses of estrogen alone insufficient for transgender females?

Which medication is widely used in Europe as an adjunctive therapy for transgender females?

What is the recommended serum estradiol and serum testosterone levels for transgender females?

What is the main concern with ethinyl estradiol in transgender treatment plans?

What is the main reason for adjunctive therapy in hormonal treatment for transgender females?

Which route of estrogen administration is considered less thrombogenic due to avoiding the “first pass effect”?

What physical change is generally maximal at 2 years after initiating hormones in transgender females?

What is the major concern for transgender females in relation to hormone therapy?

How often should laboratory monitoring of sex steroid hormone levels be conducted during the first year of hormone therapy for transgender individuals?

Which effect is not expected to occur during the first 1 to 6 months of testosterone therapy for transgender males?

What is the onset time for breast growth in transgender females undergoing hormone therapy?

Which physical change is not expected in transgender females during the first 3 to 12 months of estrogen and antiandrogen therapy?

Which of the following is not a potential adverse event resulting from excess testosterone therapy in transgender males?

What is the target serum testosterone level for transgender males receiving testosterone enanthate/cypionate injections?

In transgender females undergoing hormone therapy, what is the recommended maximum serum estradiol level?

What is the recommended frequency for measuring hematocrit or hemoglobin in transgender males during the first year of hormone therapy?

In transgender females treated with estrogens, what percentage may have elevations in prolactin levels associated with enlargement of the pituitary gland?

For individuals on spironolactone, how often should serum electrolytes, particularly potassium, be monitored during the first year?